NOVARTIS N (Germany) Price Patterns
| NOT Stock | 134.00 0.45 0.34% |
Momentum
Buy Stretched
Oversold | Overbought |
The summary pairs NOVARTIS N's headline activity with price response context.
The sentiment panel for NOVARTIS N aggregates attention signals from headlines and public sources.
NOVARTIS N after-hype prediction price | € 133.47 |
Sentiment indicators are framed alongside forecasting, technical analysis, analyst estimates, and momentum.
NOVARTIS |
Mean reversion in NOVARTIS N is distinct from trend following. Where trend followers ride price momentum, mean reversion investors bet that extended moves will reverse once the underlying driver runs out of fuel.
After-Hype Price Density Analysis
Probability distribution analysis for NOVARTIS N provides an objective framework for evaluating risk/reward tradeoffs. By comparing the width of NOVARTIS N's upside distribution against the downside, investors can make more calibrated position sizing decisions.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The empirical analysis of NOVARTIS N's news impact provides an evidence-based estimate of potential price movement around upcoming announcements. NOVARTIS N's after-hype downside and upside margins for the prediction period are 132.26 and 134.68, respectively. This estimate is conditional on the type and significance of the news event and should be interpreted in that context for NOVARTIS N.
Current Value
The after-hype framework applied to NOVARTIS N assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as NOVARTIS N is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NOVARTIS N backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NOVARTIS N, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 1.21 | 0.53 | 0.27 | 1 Events | 1 Events | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
134.00 | 133.47 | 0.40 |
|
Hype Timeline
NOVARTIS N is now traded for 134.00on Stuttgart Exchange of Germany. The company has historical hype elasticity of -0.53, and average elasticity to hype of competition of 0.27. NOVARTIS is anticipated to decline in value after the next headline, with the price expected to drop to 133.47. The average volatility of media hype impact on the company price is about 80.13%. The price decline on the next news is expected to be -0.4%, whereas the daily expected return is now at 0.35%. The volatility of related hype on NOVARTIS N is about 154.28%, with the expected price after the next announcement by competition of 134.27. The company has Price/Earnings To Growth (PEG) ratio of 2.61. NOVARTIS N had not issued any dividends in recent years. The company completed a 6:5 stock split on 4th of October 2023. Assuming the 90-day trading horizon the next anticipated press release will be very soon. NOVARTIS N Basic Forecasting Models provides a cross-check on projections for NOVARTIS N. This adds a model-based reference for the projection set.Related Hype Analysis
By analyzing how NOVARTIS N's sector peers have historically reacted to different types of news, investors can build a mental model of the sentiment dynamics that typically precede changes in NOVARTIS N's own price.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 9JI | Aussie Broadband Limited | 0.00 | 4 per month | 1.62 | 0.04 | 6.12 | -3.00 | 25.52 | |
| QCH | Computershare Limited | 0.59 | 5 per month | 0.00 | -0.04 | 3.30 | -2.67 | 8.41 | |
| FOO | Salesforce | 4.92 | 9 per month | 0.00 | -0.08 | 4.22 | -6.44 | 14.31 | |
| IE2A | Internet Thailand PCL | 0.00 | 5 per month | 1.57 | 0.09 | 3.41 | -2.25 | 11.62 | |
| ISHA | INTERSHOP Communications Aktiengesellschaft | 0.03 | 2 per month | 2.62 | 0.04 | 6.35 | -5.22 | 17.73 | |
| MNL | MUTUIONLINE | 0.00 | 0 per month | 0.00 | -0.26 | 0.54 | -2.15 | 6.45 | |
| E3B | Eutelsat Communications | -0.05 | 5 per month | 3.63 | 0.03 | 11.42 | -5.53 | 23.38 |
NOVARTIS N Additional Predictive Modules
Most predictive techniques to examine NOVARTIS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NOVARTIS using various technical indicators. When you analyze NOVARTIS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for NOVARTIS N evaluates news tone, positioning, and narrative momentum. Sentiment regime can shift quickly alongside liquidity conditions. NOVARTIS N has a market cap of 160.08 B.
Data shown for NOVARTIS N is aggregated from periodic company reporting and market reference feeds and normalized across reporting formats. Source publication cadence can introduce delays.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardThematic Opportunities
Explore Investment Opportunities
Additional Tools for NOVARTIS Stock Analysis
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |